Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report

被引:0
|
作者
Zhuang, Hongkai [1 ,2 ]
Ma, Zuyi [1 ,2 ]
Wu, Yanxia [3 ]
Yin, Zi [1 ]
Jian, Zhixiang [1 ]
Zhang, Chuanzhao [1 ]
Hou, Baohua [1 ]
机构
[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gen Surg, 106 Zhongshan Er Rd, Guangzhou 510080, Peoples R China
[2] Shantou Univ, Med Coll, Shantou 515000, Peoples R China
[3] Sun Yat Sen Univ, Sch Med, Guangzhou 510080, Peoples R China
基金
中国国家自然科学基金;
关键词
Castleman disease; neo-adjuvant chemotherapy; plasma cell type; case report;
D O I
10.21037/tcr.2020.02.45
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Here we introduced a successful case showing neo-adjuvant chemotherapy followed by radical resection for a borderline resectable unicentric Castleman disease (UCD). This study demonstrated that neo-adjuvant rituximab in combination with cyclophosphamide, epirubicin, vincristine and prednisone (R-CHOP) chemotherapy alleviated the symptom of plasma cell type of Castleman disease (PCCD) as well as downsized the tumor to provide an opportunity for radical surgical resection. It would contribute to the treatment for borderline resectable or unresectable UCD in the future.
引用
收藏
页码:3030 / 3033
页数:4
相关论文
共 50 条
  • [1] Neo-adjuvant chemotherapy or chemoradiotherapy followed by surgery for resectable oesophageal cancer
    Higgs, SM
    Barham, C
    Blazeby, JM
    Moorghen, M
    Vickers, J
    Alderson, D
    BRITISH JOURNAL OF SURGERY, 2004, 91 : 6 - 6
  • [2] CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
    Astrid E. Slagter
    Edwin P. M. Jansen
    Hanneke W. M. van Laarhoven
    Johanna W. van Sandick
    Nicole C. T. van Grieken
    Karolina Sikorska
    Annemieke Cats
    Pietje Muller-Timmermans
    Maarten C. C. M. Hulshof
    Henk Boot
    Maartje Los
    Laurens V. Beerepoot
    Frank P. J. Peters
    Geke A. P. Hospers
    Boudewijn van Etten
    Henk H. Hartgrink
    Mark I. van Berge Henegouwen
    Grard A. P. Nieuwenhuijzen
    Richard van Hillegersberg
    Donald L. van der Peet
    Heike I. Grabsch
    Marcel Verheij
    BMC Cancer, 18
  • [3] CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
    Slagter, Astrid E.
    Jansen, Edwin P. M.
    van Laarhoven, Hanneke W. M.
    van Sandick, Johanna W.
    van Grieken, Nicole C. T.
    Sikorska, Karolina
    Cats, Annemieke
    Muller-Timmermans, Pietje
    Hulshof, Maarten C. C. M.
    Boot, Henk
    Los, Maartje
    Beerepoot, Laurens V.
    Peters, Frank P. J.
    Hospers, Geke A. P.
    van Etten, Boudewijn
    Hartgrink, Henk H.
    Henegouwen, Mark I. van Berge
    Nieuwenhuijzen, Grard A. P.
    van Hillegersberg, Richard
    van der Peet, Donald L.
    Grabsch, Heike I.
    Verheij, Marcel
    BMC CANCER, 2018, 18
  • [4] Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
    Dikken, Johan L.
    van Sandick, Johanna W.
    Swellengrebel, H. A. Maurits
    Lind, Pehr A.
    Putter, Hein
    Jansen, Edwin P. M.
    Boot, Henk
    van Grieken, Nicole C. T.
    van de Velde, Cornelis J. H.
    Verheij, Marcel
    Cats, Annemieke
    BMC CANCER, 2011, 11
  • [5] Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
    Johan L Dikken
    Johanna W van Sandick
    HA Maurits Swellengrebel
    Pehr A Lind
    Hein Putter
    Edwin PM Jansen
    Henk Boot
    Nicole CT van Grieken
    Cornelis JH van de Velde
    Marcel Verheij
    Annemieke Cats
    BMC Cancer, 11
  • [6] A case report of neo-adjuvant chemotherapy against vaginal cancer
    Imamura, K
    Fujiyoshi, K
    Ohkura, N
    Mori, C
    Ota, S
    Hirai, N
    Sugiyama, T
    Yakushiji, M
    XVI ASIAN AND OCEANIC CONGRESS OF OBSTETRICS AND GYNAECOLOGY, 1998, : 27 - 29
  • [7] Complete resection of unicentric Castleman disease in the superior mediastinum: A case report
    Haro, Akira
    Kuramitsu, Erina
    Fukuyama, Yasuro
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2016, 25 : 44 - 47
  • [8] A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy
    Xiaolong Wei
    Chunfa Chen
    Didi Xi
    Jinwen Bai
    Wenhe Huang
    Luoxiang Rong
    Mingyao Wu
    Guojun Zhang
    Frontiers of Medicine, 2015, 9 (01) : 112 - 116
  • [9] A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy
    Wei, Xiaolong
    Chen, Chunfa
    Xi, Didi
    Bai, Jinwen
    Huang, Wenhe
    Rong, Luoxiang
    Wu, Mingyao
    Zhang, Guojun
    FRONTIERS OF MEDICINE, 2015, 9 (01) : 112 - 116
  • [10] A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy
    Xiaolong Wei
    Chunfa Chen
    Didi Xi
    Jinwen Bai
    Wenhe Huang
    Luoxiang Rong
    Mingyao Wu
    Guojun Zhang
    Frontiers of Medicine, 2015, 9 : 112 - 116